OLFM2 and metabolic dysfunction-associated steatotic liver disease: Since we first described the association between OLFM2 and NAFLD and increased expression of OLFM2 in adipose tissue was reported in the HPA [18], we wanted to investigate the relative mRNA expression of OLFM2 in the current research in SAT and VAT and study its role in adipose-tissue–liver-axis-mediated NAFLD in a well-established cohort of women with normal weight (NW) or MO who had different degrees of NAFLD involvement.